Cited by 27Endometriosis Research and TreatmentOvarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments

Endometriosis and ovarian cancer

Open access
Králíčková, Milena·2014·World Journal of Clinical Oncology

Abstract

Endometriosis is the leading cause of morbidity among premenopausal women and the complex pathogenesis of this disease remains controversial despite extensive research. This disease represents one of the most common gynecological problems. It is generally believed that this disease is due primarily to retrograde menstruation or transplantation of shed endometrium. Based on overwhelming data, ovarian endometrioma is considered a neoplastic process, since most endometriosis-associated ovarian carcinoma occur in the presence of atypical ovarian endometriosis. A study comparing patients with typical epithelial ovarian cancer with endometriosis-associated ovarian cancer demonstrated that the patients with the latter disease strongly differ in both biological and histological characteristics. The prevelance of this disease is not completely established, but approximately 15 percent of women suffer from this disease. In addition, we know about the possible links between endometriosis and cancer for almost 100 years. Despite clear evidence revealing that endometriosis increases ovarian cancer risks, it is possible that it may not affect disease progression after the appearance of ovarian cancer. However, despite clear evidence revealing that endometriosis increases ovarian cancer risk, our knowledge of the risk factors is far from established. In our review, we focused on the most recent approaches including possible biomarkers and genetic approaches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5306/wjco.v5.i5.800

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Infertility and delayed menopause increase the risk, while hysterectomy, use of oral contraceptives, and tubal ligation decrease the risk and are common risk factors.

    “Infertility and delayed menopause increase the risk, while hysterectomy, use of oral contraceptives, and tubal ligation decrease the risk and are common risk factors [12].”
  • Disruption of redox metabolism may lead to the acquisition of cancer-specific metabolism in clear cell carcinoma.

    “It has also been reported that endometriosis causes a disruption of redox metabolism, which may lead to the acquisition of cancer-specific metabolism in clear cell carcinoma [12].”
  • Endometriosis causes a disruption of redox metabolism.

    “It has also been reported that endometriosis causes a disruption of redox metabolism, which may lead to the acquisition of cancer-specific metabolism in clear cell carcinoma [12].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. von Rokytansky C. Uber uterusdrusen-neubildung in ute- rus inder ovarilsarcomen. Z Ges Artze Wein 1860; 37: 577-593

Cited by

Sorted by citations

Authors
Králíčková, M.
Affiliations
Charles University (CZ)
Corresponding author
Králíčková, Milena
Venue
World Journal of Clinical Oncology
Published
2014
Volume
5
Issue
5
Pages
800
ISSN
2218-4333 (ISSN-L)
OpenAlex
W2032878994
Cited by
27
References
66
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 3
FWCI
2.83
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • World Journal of Clinical Oncology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
endometriosis, ovarian cancer, endometriosis-associated ovarian cancer, endometrioma, atypical endometriosis, retrograde menstruation, endometriosis pathogenesis, cancer risk factors, biomarkers, genetic susceptibility

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review